Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Melanocortin Receptor 4 Agonist PL8905 in Combination With Glucagon-Like Peptide 1 Produces Synergistic Weight Loss, Reduced food Intake, and Greater Glucose Control in Diet-Induced Obese Rats

Scroll to Top